The Industrial Phase-Transfer Catalysis Experts

PTC Tip of the Month E-Newsletter

PTC Tip of the Month - August 2016

Is Such A High Excess Necessary?

By Marc Halpern, the leading expert in industrial phase-transfer catalysis.

Last week, two patents that were published using PTC also used THF as solvent and both appear to use conditions that were somewhat disappointing. One will be described in the PTC Tip of the Month here and the other will be described in the PTC Reaction of the Month below.

US Patent 9,422,305 describes the etherification of a diol with epichlorohydrin to form the diglycidyl ether (bisepoxide). The disappointing warning sign is that the inventors used 14 equivalents of epichlorohydrin and 12 equivalents of NaOH when they needed only 2 equivalent in theory. Why would they need such huge excesses of reactants?

bisepoxynorbornyl
The inventors note “intense” stirring of a huge excess of the epichlorohydrin in the presence of the concentrated NaOH while dropping in the diol “slowly”. It may be speculated that the intense stirring could promote hydrolysis of the epichlorohydrin, especially since the diol is being added last leaving the epichlorohydrin open to attack before the diol is available to consume the epi. Addition of THF could also promote hydrolysis by co-dissolving some water/base with the epichlorohydrin and organic epoxide product.

Unless a PTC system is transfer rate limited (etherifications are typically intrinsic reaction rate limited not transfer rate limited), in cases in which there are water-sensitive reactants and products, it is usually preferable to reduce the agitation efficiency and allow the phase-transfer catalyst to bring the reactants together while minimizing non-catalyzed interfacial hydrolysis of the sensitive functional group (epoxide in this case). In addition, PTC enables us to use a less polar solvent that would reduce contact between hydroxide and the epoxide keeping them separated in different phases. All this would possibly reduce the huge excess of epi being used.

One impressive aspect of this reaction is that the etherification to the glycidyl ether takes place at room temperature. Many PTC etherifications with epichlorohydrin are reported at temperatures of about 80oC. The bromide of TBAB is likely forming epibromohydrin in situ that is more reactive than epichlorohydrin, thereby co-catalyzing the reaction.

In short, we expect that by using a non-polar solvent to separate the base from the epoxide starting material and product, avoiding over-agitation and better choice of base (perhaps with potassium salt to enhance the formation of an omega phase), the large excess of starting materials can be avoided.

To learn more about how to optimize PTC etherifications to improve process performance and profit, now contact Marc Halpern of PTC Organics.

About Marc Halpern

Marc Halpern

Dr. Halpern is founder and president of PTC Organics, Inc., the only company dedicated exclusively to developing low-cost high-performance green chemistry processes for the manufacture of organic chemicals using Phase Transfer Catalysis. Dr. Halpern has innovated PTC breakthroughs for pharmaceuticals, agrochemicals, petrochemicals, monomers, polymers, flavors & fragrances, dyes & pigments and solvents. Dr. Halpern has provided PTC services on-site at more than 260 industrial process R&D departments in 37 countries and has helped chemical companies save > $200 million. Dr. Halpern co-authored five books including the best-selling “Phase-Transfer Catalysis: Fundamentals, Applications and Industrial Perspectives” and has presented the 2-day course “Practical Phase-Transfer Catalysis” at 50 locations in the US, Europe and Asia.

Dr. Halpern founded the journal “Industrial Phase-Transfer Catalysis” and “The PTC Tip of the Month” enjoyed by 2,100 qualified subscribers, now beyond 130 issues. In 2014, Dr. Halpern is celebrating his 30th year in the chemical industry, including serving as a process chemist at Dow Chemical, a supervisor of process chemistry at ICI, Director of R&D at Sybron Chemicals and founder and president of PTC Organics Inc. (15 years) and PTC Communications Inc. (20 years). Dr. Halpern also co-founded PTC Interface Inc. in 1989 and PTC Value Recovery Inc. in 1999. His academic breakthroughs include the PTC pKa Guidelines, the q-value for quat accessibility and he has achieved industrial PTC breakthroughs for a dozen strong base reactions as well as esterifications, transesterifications, epoxidations and chloromethylations plus contributed to more than 100 other industrial PTC process development projects.

Dr. Halpern has dedicated his adult life to his family and to phase-transfer catalysis (in that order!).

Leave a Reply

Your email address will not be published. Required fields are marked *

PTC Course - In-House

Learn to choose
PTC process conditions
LIKE AN EXPERT!

Learn More